CRMD : Summary for CorMedix Inc - Yahoo Finance

U.S. Markets open in 1 hr 42 mins

CorMedix, Inc. (CRMD)

NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
1.70-0.04 (-2.30%)
At close: 4:02PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close1.74
Bid0.00 x
Ask0.00 x
Day's Range1.63 - 1.77
52 Week Range1.35 - 4.54
Avg. Volume204,698
Market Cap68.55M
PE Ratio (TTM)-2.62
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire3 days ago

    CorMedix Inc. Makes NYSE MKT Section 610(b) Public Announcement

    BEDMINSTER, NJ / ACCESSWIRE / March 23, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...

  • CorMedix, Inc. :CRMD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube6 days ago

    CorMedix, Inc. :CRMD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis CorMedix, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of CorMedix, Inc. – Becton, Dickinson and Company, Emergent BioSolutions Inc., Utah Medical Products, Inc., Tetraphase Pharmaceuticals, Inc. and Achaogen, Inc. (BDX-US, EBS-US, UTMD-US, TTPH-US and AKAO-US) that have also ... Read more (Read more...)

  • MarketWatch10 days ago

    CorMedix's stock plunges after warning that it may run out of cash

    Shares of CorMedix Inc. plunged 22% in premarket trade Friday, after the biopharmaceutical company said it currently didn't have enough cash to fund operations through 2017, given expected clinical trial ...